Levothyroxine Sodium Tablets
Reason Sub-Potent Drug: Out of specification for assay at the 24 month interval.
14,450 recalls · Class II, newest first
Reason Sub-Potent Drug: Out of specification for assay at the 24 month interval.
Reason Lack of assurance of sterility: Medial fill with presence of Cupriavidus pauculus.
Reason Failed Impurities/Degradation Specifications: High Out Of Specification degradation results.
Reason CGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the same conditions as the lots found to be contaminated.
Reason CGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the same conditions as the lots found to be contaminated.
Reason Subpotent Drug
Reason Subpotent Drug
Reason Subpotent Drug
Reason Subpotent Drug
Reason Subpotent Drug
Reason Subpotent Drug
Reason Subpotent Drug
Reason Subpotent Drug
Reason Subpotent Drug
Reason Subpotent Drug
Reason Subpotent Drug
Reason Subpotent Drug
Reason Subpotent Drug
Reason Subpotent Drug
Reason Subpotent Drug
Reason Failed Dissolution Specification: Out of specification dissolution results at time point zero. The OOS was above specified values.
Reason CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.
Reason CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.
Reason CGMP Deviations: Voluntary recall of all hand sanitizer distributed after March 31, 2022, due to FDA issued guidance to cease placing hand sanitizer product, produced under temporary approval, into the market after March 31, 2022.
Reason CGMP Deviations: Voluntary recall of all hand sanitizer distributed after March 31, 2022, due to FDA issued guidance to cease placing hand sanitizer product, produced under temporary approval, into the market after March 31, 2022.